The DEA’s Potential Rescheduling of Marijuana (which is definitely a psychedelic)
The U.S. Drug Enforcement Administration (DEA) is reviewing marijuana’s classification under the Controlled Substances Act following a recommendation by Health and Human Services (HHS). HHS proposed moving marijuana from Schedule I to III which would acknowledge its medical benefits while decreasing federal restrictions and legal consequences associated with research and the legal cases relating to […]
Examining Ketamine Therapy As a Workplace Benefit
Introduction In the rising global mental health epidemic severe challenges, such as depression, anxiety, and post-traumatic stress disorder (PTSD), continue to significantly impact employee well-being and productivity. Employers are increasingly seeking effective and innovative solutions to support workforce mental health. An intriguing treatment option that has emerged in recent years is ketamine assisted therapy. Although […]
Celebrating Bicycle Day with Tricycle Day: Your Weekly Psychedelic Digest
Today is Bicycle Day and on the anniversary of Albert Hofmann’s pioneering LSD trip, today is also a great time to highlight a key resources within the psychedelic community: the Tricycle Day newsletter. With over 45,000 subscribers – it provides comprehensive research updates, policy analyses and business insight in less than 10 minutes each week! […]
The Aspen Psychedelic Symposium 2024: Where Ancient Wisdom Meets Modern Science
Aspen, Colorado is experiencing something truly incredible as its citizens experience a remarkable revival of one of humanity’s oldest medicines – psychedelics. From May 31st-2024 Aspen’s Wheeler Opera House will host an unprecedented gathering in which ancient psychedelic wisdom meets modern science and clinical research for an incredible experience – the Aspen Psychedelic Symposium. Organized […]
Porta Sophia: Protecting Public Domain Innovation in Psychedelic Science
Porta Sophia is playing an invaluable role in protecting public domain and ethical advancement in psychedelic research and innovation, especially as the popularity of psychedelic therapies increases, increasing the potential for overly broad patents that could prevent access to potentially lifesaving treatments.
Psychedelics Design: Exploring the Intersection of Consciousness and Creativity
At its core, Psychedelics Design is a platform that investigates the potential of psychedelics through the lens of design. It serves as a space for creatives, psychedelic enthusiasts, and forward-thinking companies to connect, inspire, and grow. By bridging art, science, design, and engineering, the project aims to explore how psychedelics can benefit people, society, and […]
Listening To The Healers: Psytelligence Psychedelic Therapist Support Survey Report
Introduction: Psychedelic therapy has transformative potential for healing and personal growth. To gain a deeper understanding of the experiences, challenges, and needs of psychedelic therapists, we conducted a formative research survey (n=30) with a diverse group of practitioners. In this article, we will delve into the themes gathered from these therapists, providing a snapshot of […]
Josh Hardman: Pioneering Psychedelic Insights and Community Engagement with Psychedelic Alpha
Josh Hardman is widely respected within the psychedelic industry for his contributions as founder and thought leader behind www.psychedelicalpha.com, an information hub dedicated to providing reliable information, strategic insights, and community engagement within this emerging space. Through this platform he serves both individuals as well as organizations seeking guidance in understanding this emerging field of […]
MindMed: Revolution in Anxiety Treatment with MM120 for Generalized Anxiety Disorder.
MindMed’s Phase 2b trial of MM120 in GAD achieved its key secondary endpoint, with 12-week topline data showing clinically and statistically significant durability of activity through Week 12. This showed how quickly clinically significant improvements on the Hamilton Anxiety Rating Scale (HAM-A) could occur and be sustained over a 12-week period after single oral administration […]
Discovering Psychedelic Wellness – open:minds EXPO
As mental health and personal well-being concerns have grown increasingly pressing in recent years, the growing awareness of psychedelic wellness as an effective approach to healing and self-discovery has captured public imagination. OPEN:MINDS Expo is an innovative event designed to demystify this complex field through engaging speaker sessions and direct interactions with industry professionals. This […]